Objective: To determine whether 17-alpha-hydroxyprogesterone caproate (17P) reduces the incidence of preterm birth (PTB) in women with a history-indicated cerclage.
Conclusions: 17P does not appear to have an effect on preterm birth <35 weeks in women with a history-indicated cerclage.
MacKeen, MD, D.; Rafael, MD, T. J.; Zavodnick, BA, J.; and Berghella, MD, V., "Effectiveness of 17-Alpha-Hydroxyprogesterone Caproate on the Prevention of Preterm Birth in Women with a History-Indicated Cerclage" (2009). Department of Obstetrics and Gynecology Faculty Papers. Paper 8.